Literature DB >> 1719184

IgG- and IgE-mediated histamine release from superfused guinea-pig airway tissues.

R G Van Amsterdam1, R E Santing, J De Boer, F Brouwer, J Zaagsma.   

Abstract

Anaphylactic histamine release and the inhibition by the beta-adrenoceptor agonist fenoterol has been investigated using lung and tracheal tissues from two groups of guinea-pigs, differently sensitized to respond with IgG or IgE antibodies, respectively. A superfusion method was introduced and compared with classical batch incubation. The difference between IgG- and IgE-mediated histamine release during superfusion of both tissues was much greater than the difference obtained during batch-incubations. Fenoterol inhibited IgG-mediated histamine release during superfusion at lower concentrations and to a larger extent than the release from IgE-sensitized tissues. The inhibition by fenoterol was less pronounced after batch-wise incubations, preincubation at 0 degrees C abolished the quantitative difference of IgG- and IgE-mediated histamine release from lung slices as well as the difference in beta-adrenergic inhibition. It is concluded that the new superfusion procedure for airway tissues enhances the sensitivity of antigen-induced histamine release for pharmacological modulation, compared with batch-wise incubation. In addition, the effects of 0 degrees C pretreatment show that cooled transport and storage of airway tissue should be considered with care.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719184     DOI: 10.1111/j.2042-7158.1991.tb03460.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Contribution of a cholinergic reflex mechanism to allergen-induced bronchial hyperreactivity in permanently instrumented, unrestrained guinea-pigs.

Authors:  R E Santing; Y Pasman; C G Olymulder; A F Roffel; H Meurs; J Zaagsma
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

2.  Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme.

Authors:  E J Franssen; R G van Amsterdam; J Visser; F Moolenaar; D de Zeeuw; D K Meijer
Journal:  Pharm Res       Date:  1991-10       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.